AI assistant
Sending…
CURIS INC — Director's Dealing 2015
Dec 30, 2015
34952_dirs_2015-12-30_39bc2aee-9ac2-44d8-a62f-4f213b4fe23a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CURIS INC (CRIS)
CIK: 0001108205
Period of Report: 2015-12-29
Reporting Person: PASSERI DANIEL R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-29 | Common stock | M | 11200 | $1.57 | Acquired | 210098 | Direct |
| 2015-12-29 | Common stock | S | 11200 | $2.91 | Disposed | 198898 | Direct |
| 2015-12-30 | Common stock | M | 14400 | $1.57 | Acquired | 213298 | Direct |
| 2015-12-30 | Common stock | S | 14400 | $3.01 | Disposed | 198898 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-29 | Employee stock option | $1.57 | M | 11200 | Disposed | 2016-05-31 | Common stock (11200) | Direct |
| 2015-12-30 | Employee stock option | $1.57 | M | 14400 | Disposed | 2016-05-31 | Common stock (14400) | Direct |
Footnotes
F1: These shares were sold between $2.81-$2.99/share pursuant to an effective 10b5-1 plan. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
F2: These shares were sold between $2.93-$3.10/share pursuant to an effective 10b5-1 plan. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
F3: Options vested over a four-year period and became fully vested on May 31, 2010.
More from CURIS INC
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 1
Annual Report
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 21
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 24
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23